J&J’s HIV vaccine fails phase 2b, extending long wait for an effective jab
J&J’s HIV vaccine fails phase 2b, extending long wait for [...]
J&J’s HIV vaccine fails phase 2b, extending long wait for [...]
GSK, Korean biotech SK go head-to-head against AstraZeneca’s COVID-19 shot [...]
A year after a death and accompanying trial hold, Poseida [...]
The descent of van de Stolpe: Galapagos CEO exits after [...]
Brain cancer biotech Ziopharm snaps up new CEO from Kuur [...]
Pfizer’s abrocitinib beats blockbuster Dupixent in phase 3 eczema trial, [...]
SPAC backs Revelation to tackle respiratory viral infections ntaylor Mon, [...]
Thwarting a cancer-promoting enzyme with a 2-pronged strategy to induce [...]
BeyondSpring, flying high from phase 3 success, sells Chinese rights [...]
Agenus, with FDA approval in sight, showcases anti-PD-1 data ntaylor [...]